Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder

Virchows Archiv

Volumn 467, Issue 6, 2015, Pages 733-740

  Szablewski, Vanessa ^a   René, Céline ^b   Costes, Valérie ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Cytotoxic; Immunodeficiency; Lymphoproliferative; Nodular regenerative hyperplasia; T cells

Indexed keywords

BILIRUBIN; CD56 ANTIGEN; CD8 ANTIGEN; DNA; GRANZYME B; IMMUNOGLOBULIN; LIVER ENZYME; LYMPHOCYTE ANTIGEN RECEPTOR; PEROXIDASE;

ADULT; ARTICLE; AUTOMATIC SLIDE STAINER; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHILD; CLINICAL FEATURE; CLONAL VARIATION; COMMON VARIABLE IMMUNODEFICIENCY; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC ERROR; GENE REARRANGEMENT; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LIVER BIOPSY; LIVER HYPERPLASIA; LIVER SINUSOID; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MALE; NODULAR REGENERATIVE HYPERPLASIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

EID: 84949528719     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-015-1862-0     Document Type: Article

References (35)

1. Mellemkjaer L, Hammarstrom L, Andersen V, et al. (2002) Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 130:495–500
2. Quinti I, Soresina A, Spadaro G, et al. (2007) Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 27:308–316. doi:10.1007/s10875-007-9075-1
3. Knowles DM (1999) Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol Off J U S Can Acad Pathol Inc 12:200–217
4. Elenitoba-Johnson KS, Jaffe ES (1997) Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 14:35–47
5. van Dongen JJM, Langerak AW, Bruggemann M, et al. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257–2317. doi:10.1038/sj.leu.2403202
6. Ziol M, Poirel H, Kountchou GN, et al. (2004) Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver. Hum Pathol 35:1241–1251
7. Llobet MP, Soler-Palacin P, Detkova D, et al. (2009) Common variable immunodeficiency: 20-yr experience at a single centre. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol 20:113–118. doi:10.1111/j.1399-3038.2008.00744.x
8. Chan H-Y, Yang Y-H, Yu H-H, et al. (2014) Clinical characteristics and outcomes of primary antibody deficiency: a 20-year follow-up study. J Formos Med Assoc Taiwan Yi Zhi 113:340–348. doi:10.1016/j.jfma.2012.07.005
9. Lin L-J, Wang Y-C, Liu X-M (2015) Clinical and immunological features of common variable immunodeficiency in China. Chin Med J 128:310–315. doi:10.4103/0366-6999.150092
10. Gathmann B, Mahlaoui N, CEREDIH, et al. (2014) Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 134:116–126. doi:10.1016/j.jaci.2013.12.1077
11. Malamut G, Ziol M, Suarez F, et al. (2008) Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 48:74–82. doi:10.1016/j.jhep.2007.08.011
12. Ward C, Lucas M, Piris J, et al. (2008) Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 153:331–337. doi:10.1111/j.1365-2249.2008.03711.x
13. Daniels JA, Torbenson M, Vivekanandan P, et al. (2009) Hepatitis in common variable immunodeficiency. Hum Pathol 40:484–488. doi:10.1016/j.humpath.2008.09.008
14. Fuss IJ, Friend J, Yang Z, et al. (2013) Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol 33:748–758. doi:10.1007/s10875-013-9873-6
15. Lal BK, Stanley A (2013) Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia. World J Gastroenterol 19:3502–3504. doi:10.3748/wjg.v19.i22.3502
16. Sander CA, Medeiros LJ, Weiss LM, et al. (1992) Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 16:1170–1182
17. Swerdlow, S., Campo E, Harris N et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition.
18. Chua I, Quinti I, Grimbacher B (2008) Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Curr Opin Hematol 15:368–374. doi:10.1097/MOH.0b013e328302c7b6
19. Canioni D, Jabado N, MacIntyre E, et al. (2001) Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria. Histopathology 38:146–159
20. Cunningham-Rundles C, Cooper DL, Duffy TP, et al. (2002) Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol 69:171–178
21. Chapel H, Cunningham-Rundles C (2009) Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 145:709–727. doi:10.1111/j.1365-2141.2009.07669.x
22. Gottesman SR, Haas D, Ladanyi M, et al. (1999) Peripheral T cell lymphoma in a patient with common variable immunodeficiency disease: case report and literature review. Leuk Lymphoma 32:589–595. doi:10.3109/10428199909058418
23. Jesus AA, Jacob CMA, Silva CA, et al. (2011) Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus. Clin Dev Immunol 2011:428703. doi:10.1155/2011/428703
24. Gammon B, Robson A, Deonizio J, et al. (2014) CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency. J Am Acad Dermatol 71:555–560. doi:10.1016/j.jaad.2014.03.028
25. Petrella T, Maubec E, Cornillet-Lefebvre P, et al. (2007) Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol 31:1887–1892. doi:10.1097/PAS.0b013e318068b527
26. Perry AM, Warnke RA, Hu Q, et al (2013) Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood Published Online First: 5 September. doi:10.1182/blood-2013-07-512830
27. Ganapathi KA, Pittaluga S, Odejide OO, et al. (2014) Early lymphoid lesions: conceptual, diagnostic and clinical challenges. Haematologica 99:1421–1432. doi:10.3324/haematol.2014.107938
28. Carvajal-Cuenca A, Campo E (2013) Early neoplastic lymphoid lesions. Semin Diagn Pathol 30:146–155. doi:10.1053/j.semdp.2012.08.008
29. Cong P, Raffeld M, Teruya-Feldstein J, et al. (2002) In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 99:3376–3382
30. Henopp T, Quintanilla-Martínez L, Fend F, et al. (2011) Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology 59:139–142. doi:10.1111/j.1365-2559.2011.03897.x
31. Mailankody S, Mena E, Yuan CM, et al. (2010) Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma. Leuk Lymphoma 51:2159–2170. doi:10.3109/10428194.2010.525725
32. De Mascarel A, Belleannée G, Stanislas S, et al. (2008) Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol 32:744–751. doi:10.1097/PAS.0b013e318159b478
33. Cellier C, Delabesse E, Helmer C, et al. (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group Lancet 356:203–208
34. Marzano AV, Berti E, Alessi E, et al. (2001) Clonal CD8 infiltration of the skin in common variable immunodeficiency: a prelymphomatous stage? J Am Acad Dermatol 44:710–713. doi:10.1067/mjd.2001.112916
35. Kimura H, Ito Y, Kawabe S, et al. (2012) EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119:673–686. doi:10.1182/blood-2011-10-381921